Skip to main content
Log in

Cytosine arabinoside triphosphate production in human leukaemic myeloblasts: Interactions with deoxycytidine

  • Original Articles
  • Cytosine Arabinoside
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

The effect of 1 μM deoxycytidine (dC) on Ara-C conversion to Ara-CTP and on inhibition of DNA synthesis by Ara-C was measured in intact leukaemic myeloblasts. dC decreased Ara-CTP production in blasts with high Ara-C phosphorylation, but not those with low activity. The Ki for dC was similar to values found with partially purified deoxycytidine kinase. The change in Ara-CTP concentration was associated with a proportional reduction in inhibition of DNA synthesis. dC decreased the effects of Ara-C by inhibition of Ara-CTP production, rather than by production of dCTP and competition with Ara-CTP. Since low Ara-CTP production in patients' blasts is a predictor of poor therapeutic response to Ara-C, the use of dC with Ara-C may improve the therapeutic index in this group of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ahern T, Taylor GA, Sanderson CJ (1976) An evaluation of an assay for DNA synthesis in lymphocytes with (3H) thymidine and harvesting onto glass fibre filter dises. J Immunol Methods 10:329–336

    Google Scholar 

  2. Bodey GP, Freireich EJ, Monto RW, Hewlett JS (1969) Cytosine arabinoside (NSC-63878) therapy for acute leukaemia in adults. Cancer Chemother Rep 53:59–66

    Google Scholar 

  3. Buchman VM, Belyanchikova NK, Mkheidze DM, Litovchenko TA, Lichinitser MR, Barkhotkina MF, Svet-Moldavsky GJ (1979) 2-deoxycytidine hydrochloride protection of mice against the lethal cytotoxicity of cytosine arabinoside. Cancer Chemother Pharmacol 3:229–234

    Google Scholar 

  4. Chabner BA, Johns DG, Coleman CN, Drake JC, Evans WH (1974) Purification and properties of cytidine deaminase from normal and leukaemic granulocytes. J Clin Invest 53:922–931

    Google Scholar 

  5. Cheng Y-C, Domin BA, Lee LS (1976) Purification and characterisation of human deoxycytidine kinase isoenzymes from blast cells of a patient with acute myelocytic leukaemia. Fed Proc 35:462

    Google Scholar 

  6. Coleman CN, Stoller RG, Drake JC, Chabner BA (1975) Deoxycytidine kinase properties of the enzyme from human leukaemic granulocytes. Blood 46:791–803

    Google Scholar 

  7. Cooper RA, Perry S, Breitman TR (1966) Pyrimidine metabolism in human leukocytes. 1. Contribution of oxogenous thymidine to DNA-thymine and its effect on thymine nucleotide synthesis in leukaemic leukocytes. Cancer Res 26:2267–2275

    Google Scholar 

  8. Durham JP, Ives DH (1969) Deoxycytidine kinase. 1. Distribution in normal and neoplastic tissues and inter-relationships of deoxycytidine and 1B-D-arabinofuranosylcytosine phosphorylation. Mol Pharmacol 5:358–375

    Google Scholar 

  9. Durham JP, Ives DH (1970a) Deoxycytidine kinase. II. Purification and properties of the calf thymus enzyme. J Biol Chem 245:2276–2284

    Google Scholar 

  10. Durham JP, Ives DH (1970b) Deoxycytidine kinase. III. Kinetics and allosteric regulation of the calf thymus enzyme. J Biol Chem 245:2285–2294

    Google Scholar 

  11. Furlong NB, Gresham C (1971) Inhibition of DNA synthesis but not poly-dAT synthesis by arabinose analogue of cytidine in vitro. Nature New Biol 233:212–213

    Google Scholar 

  12. Hande KR, Chabner BA (1978) Pyrimidine nucleoside monophosphate kinase from human leukaemic blast cells. Cancer Res 38:579–585

    Google Scholar 

  13. Harris AL, Potter C, Bunch C, Boutagy J, Harvey DJ, Grahame-Smith DG (1979) Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia. Br J Clin Pharmacol 8:219–227

    Google Scholar 

  14. Harris AL, Grahame-Smith DG, Potter CG, Bunch C (to be published) Cytosine arabinoside deamination in human leukaemic myeloblasts and resistance to cytosine arabinoside therapy. Clin Sic

  15. Henderson JF, Brox LW, Fraser JH, Lomax CA, McCoy EE, Snyder F, Sombor G (1975) Models and methods for biochemical studies of resistance in man. In: Pharmacological basis of cancer chemotherapy. Williams & Wilkins, Baltimore, pp 663–680

    Google Scholar 

  16. Kessel D (1968) Properties of deoxycytidine kinase partially purified from L1210 cells. J Biol Chem 243:4729–4744

    Google Scholar 

  17. Kessel D, Hall TC, Rosenthal D (1969) Uptake and phosphorylation of cytosine arabinoside by normal and leukaemic blood cells in vitro. Cancer Res 29:459–463

    Google Scholar 

  18. Kozai Y, Sugino Y (1971) Enzymatic phosphorylation of 1-B-D-arabinofuranosylcytosine. Cancer Res 31:1376–1382

    Google Scholar 

  19. Meyers MB, Kreis W (1976) Purification of deoxycytidine kinase from two P815 murine neoplasms and their separation from deoxyguanosine kinase. Arch Biochem Biophys 177:10–15

    Google Scholar 

  20. Mintz CG, Agent C, Furlong NB (1976) A rapid enzymatic procedure for production of 1 B-D-(3H)-arabinofuranosylcytosine 5′triphosphate. Anal Biochem 75:153–159

    Google Scholar 

  21. Momparler RL, Brent TP, Labitan A, Krygier V (1971) Studies on the phosphorylation of cytosine arabinoside in mammalian cells. Mol Pharmacol 7:413–419

    Google Scholar 

  22. Mourad N, Parks RE Jr (1966) Erythrocyte nucleoside diphosphokinase. J Biol Chem 241:271–278

    Google Scholar 

  23. Mulder JH, Harrap KR (1975) Cytosine arabinoside uptake by tumour cells in vitro. Eur J Cancer 11:373–380

    Google Scholar 

  24. Munro HN, Fleck A (1968) The determination of nucleic acids. Methods Biochem Anal 14:113–176

    Google Scholar 

  25. Plagemann PG, Marz R, Wohlhueter RM (1978) Transport and metabolism of deoxycytidine and 1-B-D-arabinofuranosylcytosine into cultured Novikoff rat hepatoma cells: relationship to phosphorylation and regulation of triphosphate synthesis. Cancer Res 38:978–989

    Google Scholar 

  26. Randerath K, Randerath E (1966) Ion-exchange thin-layer chromatography. XV. Preparation properties and applications of paper like PEI-cellulose sheets. J Chromatogr 22:110–117

    Google Scholar 

  27. Schrecker AW (1970) Metabolism of 1-B-D-arabinofuranosylcytosine in leukaemia L1210: nucleoside and nucleotide kinases in cell-free extracts. Cancer Res 30:632–641

    Google Scholar 

  28. Stoller RG, Myers CE, Chasner BA (1978) Analysis of cytidine deaminase and tetrahydrouridine interaction by use of ligand techniques. Biochem Pharmacol 27:53–59

    Google Scholar 

  29. Tattersall MNH, Ganeshaguru K, Hoffbrand AV (1974) Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside. Br. J Haematol 27:29–46

    Google Scholar 

  30. Young RSK, Fischer GA (1968) The action of arabinosylcytosine on synchronously growing populations of mammalian cells. Biochem Biophys Res Commun 32:23–29

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harris, A.L., Grahame-Smith, D.G. Cytosine arabinoside triphosphate production in human leukaemic myeloblasts: Interactions with deoxycytidine. Cancer Chemother. Pharmacol. 5, 185–192 (1981). https://doi.org/10.1007/BF00258478

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00258478

Keywords

Navigation